Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 1
2010 1
2016 1
2018 1
2019 1
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene mutations: a systematic review.
Malakasioti G, Iancu D, Tullus K. Malakasioti G, et al. Pediatr Nephrol. 2021 Jun;36(6):1353-1364. doi: 10.1007/s00467-020-04695-0. Epub 2020 Jul 10. Pediatr Nephrol. 2021. PMID: 32651716 Review.
BACKGROUND: Calcineurin inhibitor (CNI) use in genetic steroid-resistant nephrotic syndrome (SRNS) is controversial as response rate is reported to be lower than non-genetic disease and no plausible mechanism of action is known. ...
BACKGROUND: Calcineurin inhibitor (CNI) use in genetic steroid-resistant nephrotic syndrome (SRNS) is controvers …
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Willis NS, Craig JC. Hodson EM, et al. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003594. doi: 10.1002/14651858.CD003594.pub4. Cochrane Database Syst Rev. 2010. PMID: 21069676 Updated. Review.
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid-resistant nephrotic syndrome (SRNS) in children. SEARCH STRATEGY: Randomised controlled trials (RCTs) were identified from the Cochrane Renal Group's speci …
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid-resistant nephrotic …
Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy.
Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Ziętkiewicz S, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schijvens AM, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Deng F, Rousset-Rouviere C, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G; PodoNet Consortium; mitoNET Consortium; CCGKDD Consortium; Schaefer F. Drovandi S, et al. Kidney Int. 2022 Sep;102(3):592-603. doi: 10.1016/j.kint.2022.02.040. Epub 2022 Apr 26. Kidney Int. 2022. PMID: 35483523 Free article.
Primary Coenzyme Q10 deficiency is a rare mitochondriopathy with a wide spectrum of organ involvement, including steroid-resistant nephrotic syndrome mainly associated with disease-causing variants in the genes COQ2, COQ6 or COQ8B. ...Classic infantile …
Primary Coenzyme Q10 deficiency is a rare mitochondriopathy with a wide spectrum of organ involvement, including steroid-resistant …
Interventions for steroid-resistant nephrotic syndrome: a systematic review.
Habashy D, Hodson EM, Craig JC. Habashy D, et al. Pediatr Nephrol. 2003 Sep;18(9):906-12. doi: 10.1007/s00467-003-1207-0. Epub 2003 Jun 26. Pediatr Nephrol. 2003. PMID: 12836096 Review.
In a systematic review and meta-analysis of randomized controlled trials (RCT), we aimed to evaluate the benefits and harms of all interventions for children with steroid-resistant nephrotic syndrome (SRNS). Nine RCTs involving 225 children were includ …
In a systematic review and meta-analysis of randomized controlled trials (RCT), we aimed to evaluate the benefits and harms of all intervent …
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID, Willis NS, Craig JC, Hodson EM. Liu ID, et al. Cochrane Database Syst Rev. 2019 Nov 21;2019(11):CD003594. doi: 10.1002/14651858.CD003594.pub6. Cochrane Database Syst Rev. 2019. PMID: 31749142 Free PMC article.
SELECTION CRITERIA: Randomised controlled trials (RCTs) and quasi-RCTs were included if they compared different immunosuppressive agents or non-immunosuppressive agents with placebo, prednisone or other agent given orally or parenterally in children aged three months to 18 years …
SELECTION CRITERIA: Randomised controlled trials (RCTs) and quasi-RCTs were included if they compared different immunosuppressive agents or …
Sphingosine phosphate lyase insufficiency syndrome: a systematic review.
Pournasiri Z, Madani A, Nazarpack F, Sayer JA, Chavoshzadeh Z, Nili F, Tran P, Saba JD, Jamee M. Pournasiri Z, et al. World J Pediatr. 2023 May;19(5):425-437. doi: 10.1007/s12519-022-00615-4. Epub 2022 Nov 12. World J Pediatr. 2023. PMID: 36371483 Review.
The most prevalent clinical feature was endocrinopathies, including primary adrenal insufficiency (PAI) (71.2%) and hypothyroidism (32.7%). Kidney disorders (42, 80.8%) were mainly in the form of steroid-resistant nephrotic syndrome (SRNS) and progress …
The most prevalent clinical feature was endocrinopathies, including primary adrenal insufficiency (PAI) (71.2%) and hypothyroidism (32.7%). …
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D, Hodson E, Craig J. Habashy D, et al. Cochrane Database Syst Rev. 2004;(2):CD003594. doi: 10.1002/14651858.CD003594.pub2. Cochrane Database Syst Rev. 2004. PMID: 15106208 Updated. Review.
The aims of this systematic review are to assess the benefits and harms of interventions used to treat idiopathic steroid resistant nephrotic syndrome (SRNS) in children. OBJECTIVES: We aimed to evaluate the benefits and harms of all interventions for …
The aims of this systematic review are to assess the benefits and harms of interventions used to treat idiopathic steroid resistan …
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Habashy D, Craig JC. Hodson EM, et al. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003594. doi: 10.1002/14651858.CD003594.pub3. Cochrane Database Syst Rev. 2006. PMID: 16625586 Updated. Review.
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid resistant nephrotic syndrome (SRNS) in children. SEARCH STRATEGY: Randomised controlled trials (RCTs) were identified from the Cochrane Central Register of …
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid resistant nephrotic …
Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review.
Jellouli M, Charfi R, Maalej B, Mahfoud A, Trabelsi S, Gargah T. Jellouli M, et al. J Pediatr. 2018 Jun;197:191-197.e1. doi: 10.1016/j.jpeds.2018.01.008. Epub 2018 Apr 18. J Pediatr. 2018. PMID: 29680473
OBJECTIVES: To evaluate the efficacy and safety of rituximab in children with steroid-resistant nephrotic syndrome. STUDY DESIGN: A systematic review evaluating the efficacy and safety of rituximab in children with steroid-resistant ne …
OBJECTIVES: To evaluate the efficacy and safety of rituximab in children with steroid-resistant nephrotic syndrome …
11 results